NIGHTSTARX LIMITED Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Pharma
Founded:N/A
Lead Investor(s):N/A

Estimated Revenue & Financials

  • NIGHTSTARX LIMITED's estimated annual revenue is currently $13.7M per year.
  • NIGHTSTARX LIMITED's estimated revenue per employee is $201,000

Employee Data

  • NIGHTSTARX LIMITED has 68 Employees.
  • NIGHTSTARX LIMITED grew their employee count by 45% last year.
  • NIGHTSTARX LIMITED currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$51.7M25719%N/A-N/A
#2
$65.9M328N/AN/A-N/A
#3
$26.7M133N/AN/A-N/A
#4
$11.3M5624%N/A-N/A
#5
$21.1M105N/AN/A-N/A
#6
$21.1M105N/AN/A-N/A
#7
$23.1M115N/AN/A-N/A
#8
$12.3M6127%N/A-N/A
#9
$32.2M160N/AN/A-N/A
#10
$21.1M105N/AN/A-N/A
Missing a competitor? Contribute!?
Submit

Nightstar Therapeutics plc (NASDAQ: NITE) is a leading clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases including choroideremia, X-linked retinitis pigmentosa and Best vitelliform macular dystrophy.

keywords:N/A

68

Number of Employees

$13.7M

Revenue (est)

1

Current Jobs

45%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

NIGHTSTARX LIMITED News

20-Mar-19 - Nightstar Therapeutics plc files 10-K

Under the SME Scheme, our principal research subsidiary company, NightstaRx Limited, may be eligible to surrender the trading losses that

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$17M68-4%N/A-N/A
#2
$11.5M6821%N/A-N/A
#3
N/A6831%N/A-N/A
#4
$9.9M685%N/A-N/A
#5
$9.9M6839%N/A-N/A